IP Library Granted Patent US 8,049,065
Granted Patent B2
US 8,049,065 · App. 12/364,293 · Granted Nov 1, 2011

Transgenic systems for the manufacture of poly(2-hydroxy-butyrate-co-3-hydroxyhexanoate)

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,049,065
App. No.
12/364,293
Granted
Nov 1, 2011
Kind
B2
Abstract

Methods for engineering transgenic organisms that synthesize polyhydroxyalkanoates (PHAs) containing 3-hydroxyhexanoate as comonomer have been developed. These processes are based on genetically engineered bacteria such as Escherichia coli or in plant crops as production systems which include PHA biosynthetic genes from PHA producers. In a preferred embodiment of the method, additional genes are introduced in wild type or transgenic polyhydroxybutyrate (PHB) producers, thereby creating new strains that synthesize 3HH monomers which are incorporated into PHAs. The 3HH monomer preferably is derived in microbial systems using butanol or butyrate as feedstocks, which are precursors of 3-hydroxyhexanoyl-CoA. Pathways for in vivo production of butyrol-CoA specifically encompassing butyryl-CoA dehydrogenase activity are provided.

Claims (30)

1. A method for producing 3-hydroxyhexanoate copolymers comprising

providing a genetically engineered plant expressing a 3-ketothiolase gene encoding an enzyme that converts butyryl-CoA and acetyl-CoA to 3-ketohexanoyl-CoA, a reductase gene that encodes an acetoacetyl-CoA reductase, and a gene that encodes a polyhydroxyalkanoate polymerase that polymerizes 3-hydroxybutyryl-CoA and 3-hydroxyhexanoyl-CoA, and

providing a source of butyrate or butanol,

wherein the plant will produce poly3-hydroxyhexanoate copolymers.

2. The method of claim 1 for producing 3-hydroxyhexanoate copolymers comprising

identifying a plant converting butyrate to butyryl-CoA,

growing the plant in the presence of butyrate or butanol such that 3-hydroxyhexanoate copolymer is produced, and

recovering the 3-hydroxyhexanoate copolymer, wherein the recovered 3-hydroxyhexanoate copolymer is polyhydroxybutyrate-co-3-hydroxyhexanoate copolymer.

3. The method of claim 1 wherein the plant is selected from the group consisting of oil crop plants and starch accumulating plants.

4. The method of claim 1 wherein the plant is selected from the group consisting of Brassica, sunflower, soybean, corn, safflower, flax, palm, coconut, potato, tapioca, cassava, alfalfa, grass, and tobacco.

5. The method of claim 1 , wherein the plants are genetically engineered by integration into the chromosome of one or more genes encoding one or more enzymes forming a fatty acid oxidation complex, wherein the fatty acid oxidation complex comprises enzymes selected from the group consisting of enzymes epimerizing S-3hydroxyhexanoyl CoA and enzymes reducing 3-ketohexanoyl CoA.

6. The method of claim 1 wherein the plant is genetically engineered to express or overexpress a PHA polymerase incorporating C6 substrates.

7. The method of claim 6 wherein the enzyme is derived from Aeromonas caviae, Comamonas testosteroni, Thiocapsia pfenigii, Chromatium vinosum, Bacillus cereus, Nocardia carolina, Nocardia salmonicolor, Rhodococcus ruber, Rhodococcus Rhodocrous , and Rhodospirilum rubrum .

8. The method of claim 1 wherein the plant is genetically engineered to redirect metabolites to production of 3-hydroxyhexanoyl-CoA.

9. The method of claim 8 wherein the plant is genetically engineered using a D-specific enoyl-CoA hydratase gene.

10. The method of 9 wherein the hydratase gene is isolated from a bacteria selected from the group consisting of R. eutropha, Klebsiella aerogenes, P. putida , and Aeromonas caviae.

11. The method of claim 1 wherein the plant is genetically engineered using a butyrate fermentation pathway.

12. The method of claim 11 wherein the butyrate fermentation pathway is from Clostridium acetobutylicium or Thermoanaerobacterium thermosaccharolyticum.

13. The method of claim 11 wherein the plant is genetically engineered to convert butyrate to butyryl CoA or butyryl CoA to crotonyl CoA.

14. The method of claim 11 wherein the plant is genetically engineered to express a broad range reductase that is active on C6 substrates.

15. The method of claim 11 wherein the plant is genetically engineered to express a polymerase that accepts 3-hydroxyhexanoyl CoA.

16. The method of claim 11 wherein the plant is genetically engineered to express a thiolase accepting acetoacetyl CoA.

17. The method of claim 11 wherein the plant is genetically engineered to express an enzyme selected from the group consisting of thiolases specific for 3-ketohexanoyl CoA, reductase active on 3-ketohexanoyl CoA, PHA polymerase that accepts 3-hydroxybutyryl CoA and 3-hydroxyhexanoyl CoA.

18. The method of claim 5 wherein the fatty acid biosynthetic enzymes are enzymes converting acyl ACP to acyl CoA.

19. The method of claim 18 where the enzymes are selected from the group consisting of ACP-CoA transacylase, acyl ACP thioesterase, and acyl CoA synthase.

20. The method of claim 19 wherein the enzymes are acyl ACP thioesterase and acyl CoA synthase.

21. The method of claim 5 wherein the plant is genetically engineered to integrate one or more nucleic acids encoding fatty acid biosynthetic enzymes derived from E. coli.

22. The method of claim 5 wherein the fatty acid oxidation complex comprises enzymes epimerizing S-3 hydroxyhexanoyl CoA and enzymes reducing 3-ketohexanoyl CoA.

23. The method of claim 22 wherein the enzymes are derived from Nocardia salmonicolor.

24. The method of claim 22 wherein the enzymes for epimerization are derived from Pseudomonas putida FaoAB complex.

Assignments (2)
ADDRESS CHANGE Recorded May 2, 2016
From: METABOLIX, INC.
To: METABOLIX, INC.
Reel/Frame 038665/0359 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 9, 2009
From: MADISON, LARA; HUISMAN, GJALT W.; PEOPLES, OLIVER P.
To: METABOLIX, INC.
Reel/Frame 023491/0197 →